"I-sarang"" will help create a society where children bring happiness
| Tests | Timing |
|---|---|
| Maternal blood test(hemoglobin, blood type, blood type antibody), urine test, rubella antibody test, hepatitis B test, syphilis test, cervical cancer screening test, ultrasound test | First visit |
| Blood pressure, weight, fetal heart rate | Entire pregnancy |
| Fetal chromosomal abnormality screening: First trimester detailed ultrasound(fetal nuchal translucency), first integrated screening test, fetal DNA screening test(NIPT test)*, chorionic villus sampling* | Weeks 11~14 |
| Fetal chromosomal abnormality screening(for Down syndrome)(quad test or the second integrated screening test), amniotic fluid test* | Weeks 15~20 |
| Second trimester detailed ultrasound | Weeks 20~24 |
| Gestational diabetes screening test, anemia test | Weeks 24~28 |
| Immune globulin injection for a Rh negative patient | Week 28 |
| Tdap vaccine | Weeks 27~36 |
| Evaluation of fetal growth and fetal well-being: Ultrasound examination or non-stress test(NST) is performed individually depending on the condition of the pregnant woman and the fetus. | After week 32 |
(*Optional tests)
This test is necessary to diagnose the presence of diabetes, cystitis, urethritis, pyelonephritis, etc. during pregnancy and preeclampsia.
※Urine tests are also performed periodically during regular checkups. A test is done to see if sugar or protein is detected in the urine. Sometimes sugar is detected in the urine during the third trimester of pregnancy. It is thought to be detected not because of diabetes, but because glucose is excreted due to the kidneys not reabsorbing it during pregnancy. Therefore, it is monitored without any special treatment. However, if glucose in the urine is detected during early pregnancy, if there is a family history of diabetes, or if the woman has been previously diagnosed with gestational diabetes, testing for gestational diabetes may be considered.
During the second trimester(15-20 weeks), a maternal blood test, called the Quad test, is performed to determine the fetus' risk of Down syndrome, Edwards syndrome, and neural tube defects. The diagnostic rate is higher when both maternal serum screening and the nuchal translucency(NT) test are performed together. This is why the Quad test is not performed alone in most cases but is performed together with the first blood test in the first trimester.
This test does not diagnose a child with a birth defect but rather determines the risk of fetal chromosomal abnormalities and the need for amniocentesis. If the results of the fetal chromosomal abnormality screening test indicate high-risk(positive) for Down syndrome or Edward syndrome, amniocentesis is considered to diagnose fetal chromosomal abnormalities. However, this does not mean that the fetus is malformed. Likewise, even if the results of this test indicate low risk(negative), it does not guarantee that there are no fetal chromosomal abnormalities. It only means that amniocentesis is less necessary. Fetal chromosomal abnormalities are not all chromosomal abnormalities. Common chromosomal abnormalities such as Down syndrome and Edward syndrome can be screened, but rare diseases cannot be screened. They are also not helpful for structural malformations(congenital heart disease, cleft lip, etc.).
However, since amniocentesis cannot be performed on all pregnant women, the purpose of this test is to screen for high-risk groups for common chromosomal abnormalities using a simple blood test.
This test is one of the fetal chromosomal abnormality screening tests. It has a higher diagnostic rate and lower false positive rate than maternal serum screening tests, so it is mainly used by high-risk pregnant women. It is highly accurate by detecting fetal DNA in the pregnant woman's blood to assess the risk of Down syndrome, Edwards syndrome, and Patau syndrome, but itis expensive and, in a twin pregnancy, the result often yields an 'inconclusive' result and has lower accuracy. Although the NIPT is more accurate, it is still a screening test just like maternal serum screening and not a diagnostic test. Therefore, high-risk results should be confirmed with chorionic villus sampling or amniocentesis. You need to consult an OBGYN to decide whether to undergo maternal serum screening or NIPT for fetal chromosomal abnormality screening, and what the differences are between these tests and diagnostic tests such as chorionic villus sampling or amniocentesis.
An amniotic fluid test uses an ultrasound to extract amniotic fluid with a long needle, which is then cultured to test fetal cells for fetal chromosomal abnormalities. It can be used to diagnose congenital infection, if suspected. Although the diagnostic rate for chromosomal abnormalities is almost 99%, it is very accurate. However, there is a risk of complications such as premature rupture of membranes(PROM) and preterm labor due to the procedure, which can lead to miscarriage or preterm birth. The specific risk is estimated to be around 0.5%. The need for amniocentesis is determined in consultation with your OBGYN.
If you are concerned about a genetic disease in your family, it is recommended that you seek professional advice about prenatal genetic counseling. To date, medical science has discovered over 4,000 genetic diseases and the number of people whose genetic structures have been discovered is increasing. Thus, in recent times, many tests are being used in clinical practice. These tests can also be used to diagnose hearing impairment, mental retardation, hereditary cerebral palsy, muscular dystrophy, hemophilia, and kidney disorders.
Gestational diabetes screening is performed between 24th and 28th weeks of pregnancy. Gestational diabetes can cause serious complications for both you and the fetus if your blood sugar levels are not controlled, so all pregnant women are tested. Regardless of whether you are fasting or not, you will drink a liquid with 50g of glucose. An hour later, healthcare provider will draw your blood to check your blood sugar. If an abnormality is found, you need to repeat the test, this time with a liquid of 100g of glucose on an empty stomach. If an abnormality is found a second time, gestational diabetes is diagnosed and blood sugar management is required.
During the second trimester, iron requirements and plasma volume increase, and hemoglobin decreases. Therefore, if anemia is diagnosed, the dosage of iron supplements can be increased to correct anemia.
Same as vaccinations during the first trimester.